Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorSargın Oruç, Ayla
dc.contributor.authorYımaz, Nafiye
dc.contributor.authorİnal, Hasan Ali
dc.contributor.authorGörkem, Ümit
dc.contributor.authorGülşen, Pınar
dc.contributor.authorUğur, Mustafa
dc.contributor.authorBüyükkağnıcı, Ümran
dc.date.accessioned2019-05-10T09:38:52Z
dc.date.available2019-05-10T09:38:52Z
dc.date.issued2016
dc.identifier.citationOruç, A. S., Yilmaz, N., İnal, H. A., Görkem, Ü., Gulsen, P., Uğur, M., & Buyukkagnici, U. (2016). A study of serum soluble CD 163 levels in women with polycystic ovary syndrome. Hormone and Metabolic Research, 48(06), 399-403.en_US
dc.identifier.issn0018-5043
dc.identifier.siciOruç, A. S., Yilmaz, N., İnal, H. A., Görkem, Ü., Gulsen, P., Uğur, M., Buyukkagnici, U. (2016). A study of serum soluble CD 163 levels in women with polycystic ovary syndrome. Hormone and Metabolic Research, 48(06), 399-403.en_US
dc.identifier.urihttps://doi.org/10.1055/s-0042-101028
dc.identifier.urihttps://hdl.handle.net/11491/523
dc.description.abstractThe aim of this study was to determine serum soluble CD163 levels in patients with polycystic ovary syndrome and its relation to clinical and metabolic parameters. Eighty-four women aged 18-45 years, 43 with polycystic ovary syndrome and 41 controls were recruited in this case-control study. Serum sCD163 levels of the groups were compared. Other metabolic, hormonal, and clinical parameters including, body mass index, HOMA-IR, highly sensitive C- reactive protein, glucose, glycated hemoglobin, lipids, luteinizing hormone, and total testosterone and waist/hip circumference were also investigated. Patients were further subgrouped according to body mass index and sCD163 levels were investigated in obese and normal weight subjects. We performed a multiple regression analysis to investigate the independent predictors affecting soluble CD163 levels. Significantly higher soluble CD163 levels were found in patients with polycystic ovary syndrome (2.11±0.65 ng/ml vs. 1.69±0.85 ng/ml, p=0.012). We detected positive correlations of sCD163 with total testosterone, total cholesterol, and luteinizing hormone (r=0.330, p=0.002, r=0.356, p<0.001 and r=0.239, p=0.030, respectively). In the multiple linear regression analysis, total testosterone was the variable associated with the elevation of serum soluble CD163 levels. Soluble CD163, which is identified as a marker of inflammation and type II diabetes, is elevated in polycystic ovary syndrome. Elevated sCD163 levels were found to be associated with total testosterone. Further studies to elucidate the exact mechanism underlying the elevation of serum soluble CD163 in polycystic ovary syndrome are needed. © Georg Thieme Verlag KG Stuttgart, New York.en_US
dc.language.isoeng
dc.publisherGeorg Thieme Verlagen_US
dc.relation.isversionof10.1055/s-0042-101028en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectInflammationen_US
dc.subjectObesityen_US
dc.subjectPolycystic Ovary Syndromeen_US
dc.subjectSoluble CD163en_US
dc.titleA study of serum soluble CD 163 levels in women with polycystic ovary syndromeen_US
dc.typearticleen_US
dc.relation.journalHormone and Metabolic Researchen_US
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.identifier.volume48en_US
dc.identifier.issue6en_US
dc.identifier.startpage399en_US
dc.identifier.endpage403en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster